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Background: Coronary collateral circulation plays an important role in protecting myocardium from ischemia and
reducing cardiovascular events. Low High-density lipoprotein cholesterol (HDL-C) level is a strong risk factor for
coronary artery disease (CAD) and is associated with poor cardiovascular outcome. It was recently reported to be
associated with poor coronary collateral development in Turkish population. Hence, we investigated the influence
of HDL-C on coronary collateral formation in Chinese population.
Methods: We evaluated 970 consecutive patients undergoing coronary angiography, and 501 patients with
significant coronary artery disease (SCAD) were finally analyzed. The collateral scoring system developed by Rentrop
was used to classify patient groups as those with poor or good collaterals.
Results: The patients with poor collaterals had fewer diseased vessels (1.97 ± 0.84 vs 2.47 ± 0.68, p < 0.001) and
lower diffuse score (2.65 ± 1.63 vs 3.76 ± 1.78, p < 0.001). There was no significant difference in HDL-C and other
variables between good and poor collaterals. Multivariate analysis showed only number of diseased vessels (odd
ratio 0.411, p < 0.001) was a significant predictor of poor collateral development.
Conclusions: The extent of CAD severity but not HDL-C level was the most powerful predictor of coronary
collateral formation in our Chinese population with SCAD.
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Cardiovascular disease is one of the leading causes of
morbidity and mortality in the world. Low high-density
lipoprotein cholesterol (HDL-C) is an independent risk
factor for coronary artery disease (CAD) and is associ-
ated with increased cardiovascular event [1-3].
The development of coronary collaterals is an adaptive
response to chronic myoischemia and serves as a con-
duit bridging the significantly stenotic coronary vessels
[4-6]. Collateral circulation can hence protect and pre-
serve myocardium from episodes of ischemia, enhance
residual myocardial contractility, and reduce angina* Correspondence: lth@kmu.edu.tw
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reproduction in any medium, provided the orsymptoms and cardiovascular events [7-9]. However,
there is inter-individual difference of coronary collateral
formation and the mechanisms for different individual
ability to develop collateral circulation are still not well
understood.
Furthermore, HDL-C was also recently reported to be
associated with poor coronary collateral development in
a Turkish population [10]. Hence, we wanted to investi-
gate the influence of HDL-C on coronary collateral for-
mation in a Chinese population with significant CAD
(SCAD).Methods
Study subjects
From February 2002 to March 2008, we evaluated 970
consecutive patients who had been scheduled to
undergo diagnostic coronary angiography at Kaohsiung. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tients with coronary artery lumen diameter stenosis < 70%,
history of coronary artery bypass surgery (CABG), history
of percutaneous coronary intervention (PCI), or those
who had inadequate angiograms for collateral evaluation.
Finally, 501 patients with significant CAD were en-
rolled in this study. Other analyzed demographic and
baseline data included gender, age, and any history of
the following: diabetes mellitus, hypertension, hyper-
cholesterolemia, body mass index, cigarette smoking,
and medications. The research protocol was approved
and registered by the ethics committee (Kaohsiung
Medical University Hospital- Institutional Review Board)
at our institution, and informed consent was obtained
from all patients.
Coronary angiography and collateral scoring
The coronary artery angiography films were reviewed by
2 experienced cardiologists blinded to the clinical and
demographic data for all patients. Any differences in in-
terpretation were resolved by a third reviewer who was
blinded to the readings of the first two reviewers. Coron-
ary artery stenosis was determined by quantitative cor-
onary angiography. The recorded data also included the
number of diseased vessels, the vessel to which the col-
laterals were connected, and the grade of coronary col-
lateral circulation. Vessels exhibiting a 70% or greater
reduction in lumen diameter were classified as SCAD. In
subjects with more than one SCAD vessel, the vessel
with the highest collateral grade was chosen for analysis.
The collateral scoring system developed by Rentrop and
Cohen was used [11]. Grades of collateral filling from
the contralateral vessel were: 0 = none; 1 = filling of side
branches of the artery to be dilated via collateral chan-
nels without visualization of the epicardial segment; 2 =
partial filling of the epicardial segment via collateral
channels; 3 = complete filling of the epicardial segment
of the artery being dilated via collateral channels. In sub-
jects with more than one collateral vessel supplying the
distal aspect of the diseased artery, the highest collateral
grade was recorded. Patients were then classified according
to their collateral grades as either poor (grade 0 or grade 1
collateral circulation) or good (grade 2 or grade 3 collateral
circulation). The coronary artery angiography films were
reviewed by two experienced cardiologists blinded to the
clinical and demographic data for all patients. Any differ-
ences in interpretation were resolved by a third reviewer
who was blinded to the readings of the first two reviewers.
The two readers obtained a 96% agreement in the collateral
classifications.
CAD severity scoring by coronary angiography
We evaluated the extent of coronary artery atheroscler-
osis by a “diffuse score” (DS) developed by Negri et al.and modified by Birnie et al. [12,13]. In brief, the coron-
ary circulation is divided into 15 segments, and eight of
them are classified as first-order segments: proximal and
middle right coronary arteries, left main coronary artery,
proximal, middle, and distal left anterior descending,
and proximal and distal circumflex. There are seven
second-order segments: distal right coronary artery, pos-
terior descending branch, obtuse marginal branch,
postero-lateral branch of circumflex, and the first two
diagonal branches of the left anterior descending artery.
The first-order segments receive a score of 1 and the
second order segments scored 0.5. The overall DS is the
sum of the individual segment scores and the maximum
score is 11.5.
Statistical analysis
All data were expressed as means ± standard deviation.
Student unpaired t-test was used to compare continuous
variables between the two groups. Chi-square test was
used to compare categorical data. Subsequently, age, sex,
significantly correlated variables in the univariate analysis
or relevant variables were further analyzed by logistic re-
gression analysis. All p values were two-sided with a sig-
nificance level of p < .05. The Statistical Package for the
Social Sciences 11.0 for Windows (SPSS Inc., Chicago, IL)
was used for statistical analysis.
Results
Clinical characteristics
Of the 970 subjects initially enrolled, 469 patients were
excluded for the following reasons: coronary artery
lumen diameter stenosis < 70%, history of CABG or PCI,
or inadequate angiograms for collateral evaluation. The
final study population was 501 subjects (396 male, 105
female; average age, 62.5 ± 12.6 years). For SCAD, 134
patients (26.7%) were one-vessel disease, 153 patients
(30.5%) were two-vessel disease, and 214 patients
(42.7%) were three-vessel disease.
Coronary collaterals
The two readers obtained a 96% agreement in the collat-
eral classifications. Of the 501 patients enrolled, 220
(43.9%) patients had no coronary collaterals. In subjects
with collaterals, the coronary grade was distributed as
follows: 91(18.2%) with grade 1, 133 (26.5%) with grade
2 and 57 (11.4%) with grade 3. Table 1 compares the
baseline characteristics between the poor group (n =
311) and the good group (n =190). The patients in the
poor group had a trend to have lower cholesterol level
(199.7 ± 45.1 vs 208.3 ± 53.6, p = 0.06), lower low-density
lipoprotein cholesterol (LDL-C) level (128.7 ± 38.3 vs
136.2 ± 43.5, p = 0.066), less angiotensin II receptor
blocker (ARB) usage (15.9% vs 22.3%, p = 0.09), and less
beta blocker usage (28% vs 36.7%, p = 0.054).
Table 1 Baseline characteristics in patients with poor and
good collaterals
Variables Poor collateral Good collateral P
value(n = 311) (n = 190)
Age (years) 62.8 ± 12.9 62.1 ± 12.1 0.547
Gender (Female, %) 22.5 18.4 0.309
DM (%) 42.8 40.5 0.642
HTN (%) 64.3 65.3 0.848
Smoking (%) 60.5 58.2 0.639
BMI 24.3 ± 6.6 24.9 ± 5.7 0.277
eGFR (mL/min/1.73 m2) 66.9 ± 26.9 68.0 ± 32.0 0.683
Laboratory data
Glucose (mg/dl) 137.7 ± 62.2 135.4 ± 60.4 0.704
Cholesterol (mg/dl) 199.7 ± 45.1 208.3 ± 53.6 0.060
LDL-C (mg/dl) 128.7 ± 38.3 136.2 ± 43.5 0.066
HDL-C (mg/dl) 37.4 ± 9.9 36.0 ± 10.6 0.175
Triglyceride (mg/dl) 168.9 ± 124.9 163.4 ± 146.4 0.660
Uric acid (mg/dl) 6.54 ± 1.94 6.58 ± 1.81 0.819
Medication
ACEI (%) 19.1 20.7 0.725
ARB (%) 15.9 22.3 0.09
Beta blocker (%) 28 36.7 0.054
ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin II receptor
blocker; BMI: body mass index; DM: diabetes; HTN: hypertension; eGFR:
estimated glomerular filtration rate; HDL-C: high-density lipoprotein
cholesterol; LDL-C: low-density lipoprotein cholesterol.
Table 3 Multivariate logistic regression analysis of
collateral circulation (good collateral group as reference
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good collaterals are shown in Table 2; the patients with
poor collaterals had fewer diseased vessels numbers
(1.97 ± 0.84 vs 2.47 ± 0.68, p < 0.001), and lower severity
scores of CAD (2.65 ± 1.63 vs 3.76 ± 1.78, p < 0.001).
Binary logistic regression analysis
Age, sex, significant variable in the univariate analysis
and relevant variables including cholesterol level, LDL-C
level, HDL-C level, ARB usage, and beta blocker usage
were included in the multivariate logistic regression ana-
lysis. We found the number of diseased vessels (OR =Table 2 Angiographic characteristics in patients with
poor and good collaterals
Mean±SD Poor collateral Good collateral P
valueNumber (%) (n = 311) (n = 190)
Number of diseased vessels 1.97 ± 0.84 2.47 ± 0.68 <0.001
Significant CAD, n (%)
1 vessel disease (%) 114 (36.7) 20 (10.5)
2 vessel disease (%) 93 (29.9) 60 (31.6) <0.001
3 vessel disease (%) 104 (33.4) 110 (57.9)
Diffuse score of CAD 2.65 ± 1.63 3.76 ± 1.78 <0.001
CAD: coronary artery disease.0.410, 95% CI = 0.31-0.55, p < 0.001) was the only signifi-
cantly independent predictor of poor coronary collat-
erals development (Table 3).
Discussion
In the current study, we investigated the influence of
HDL-C on coronary collateral formation in Chinese
population with SCAD and found two major findings.
First, HDL-C was not significantly associated with cor-
onary collateral formation in a Chinese population as a
previous study in a Turkish population. Second, the
number of diseased vessels was the only significantly in-
dependent predictor of poor coronary collaterals in the
Chinese population. This finding was also different from
previous studies in a Turkish population.
The association between HDL-C level and coronary
collaterals
HDL-C has been reported to have anti-atherogenic, anti-
inflammatory, and antioxidant properties in the litera-
ture [14-16]. Although Sumi M et al. also showed that
reconstituted HDL-C directly stimulates endothelial pro-
genitor cell differentiation via phosphatidylinositol 3-
kinase/Akt pathway and enhances ischemia-induced
angiogenesis, we did not find HDL-C was associated
with coronary collateral development in this population
study [17]. In addition, Low HDL-C level was a strong
risk factor for coronary artery disease and was associated
with poor cardiovascular outcome [1-3]. In a previous
study, Turhan H et al. reported that the development of
coronary collateral vessels is poorer in patients with
metabolic syndrome with advanced ischemic heart dis-
ease than in control participants without metabolic syn-
drome in a Turkish population, which suggested that
metabolic syndrome is one of the significant factors af-
fecting the development of coronary collateral vessels
adversely [18]. Although low HDL-C is one of thegroup)
B OR 95% CI p value
Gender (male vs female) −0.268 0.765 0.42-1.41 0.390
Age 0.010 1.010 0.99-1.03 0.326
Cholesterol (mg/dl) 0.003 1.003 0.99-1.01 0.440
LDL-C (mg/dl) −0.007 0.993 0.98-1.00 0.135
HDL-C (mg/dl) 0.018 1.018 0.99-1.04 0.160
ARB usage −0.422 0.656 0.37-1.17 0.155
Beta blocker usage −0.380 0.684 0.42-1.11 0.126
Number of diseased vessels −0.892 0.410 0.31-0.55 <0.001
ARB: angiotensin II receptor blocker; HDL-C: high-density lipoprotein
cholesterol; LDL-C: low-density lipoprotein cholesterol.
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report and we also did not find HDL-C was associated
with coronary collateral formation. Recently, Kadi H
et al. further investigated the relationship between HDL-C
and coronary collateral formation in patients with SCAD
and found that there was a positive relationship between
HDL-C and coronary collateral formation and suggested
that low HDL-C is an independent predictor of poor cor-
onary collateral formation in a Turkish population [10].
However, Li CC et al. reported that severity of coronary
stenosis was the major influencing factor in coronary col-
lateral formation and function in a Chinese population.
Serum HDL-C was not associated with coronary collateral
formation, but related to coronary collateral function
which was evaluated by the size of the collateral connec-
tion diameter [19]. In our study, we analyzed 501 Chinese
patients with SCAD to evaluate the correlation between
HDL-C and coronary collaterals. Our result showed there
was no significant association between HDL-C and coron-
ary collateral formation not only in univariate but also in
multivariate analysis, which was different from a previous
study in a Turkish population. The advantages of our
study were that we had a larger sample size and selected
more severe coronary artery lesions than the previous
study [10]. In their study, the sample size was relatively
small and vessels with 50-70% stenosis were selected for
coronary collateral evaluation, which may not cause severe
myoischemia to induce coronary collateral formation [6].
In addition, the influence of HDL-C for coronary collat-
eral development might not be similar between different
races because of genetic diversity. However, the detailed
mechanism still needs further investigation.
The association between CAD severity and coronary
collaterals
It is well known that coronary collateral formation is
mainly dependent on CAD severity [20-22]. Coronary col-
lateral formation is an adaptive response to chronic
myoischemia and serves as a conduit bridging significantly
stenotic coronary vessels. More severe and extensive myo-
cardial ischemia such as multi-vessel diseases may further
stimulate the development of coronary collateral circula-
tion. Hence, patients with good coronary collaterals ap-
pear to have a more extensive CAD. In previous studies,
number of diseased vessels was a significant predictor of
good collateral formation [20,23]. In our study, number of
diseased vessels was not only associated with good collat-
eral formation in univariate analysis but in multivariate
analysis as well. In addition, we also used DS to further
evaluate the extent of CAD severity and found that there
was also a significant difference of DS between patients
with poor and good coronary collaterals. Hence, extent of
coronary atherosclerosis significantly plays an important
role in coronary collateral formation [24,25].Limitations of the present study
First, the collateral formation was assessed by coronary
angiography in this study. Measuring collateral flow
index by intravascular Doppler guidewire may provide a
more objective physiological measurement of collateral
grade. However, the invasiveness of intravascular ultra-
sound limits its use in large-scale studies. Second, since
this was only a clinical observational study, potential
mechanisms were not fully elucidated. Third, we did not
analyze the size of the collateral connection diameter to
evaluate the coronary collateral function.
Conclusions
In conclusion, our data revealed that HDL-C was not as-
sociated with coronary collateral formation in a Chinese
population with SCAD; however, CAD severity impli-
cated by number of diseased vessels was the only signifi-
cant predictor of coronary collateral development in our
study.
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